Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient (Q33489423)

27 July 2017

title

Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient (English)

1 reference

27 July 2017

1 reference

H Albrecht

1

1 reference

27 July 2017

H J Stellbrink

2

1 reference

27 July 2017

G Gross

3

1 reference

27 July 2017

B Berg

4

1 reference

27 July 2017

U Helmchen

5

1 reference

27 July 2017

H Mensing

6

1 reference

27 July 2017

publication date

1 December 1994

1 reference

Journal of Molecular Medicine

27 July 2017

published in

1 reference

27 July 2017

volume

72

1 reference

27 July 2017

issue

12

1 reference

27 July 2017

page(s)

1041-1047

1 reference

A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS).

27 July 2017

cites work

1 reference

12 December 2020

[Leishmaniasis of the upper gastrointestinal tract in an HIV positive patient]

1 reference

12 December 2020

Visceral leishmaniasis (kala azar) in a patient with AIDS

1 reference

12 December 2020

Gastric localization of systemic leishmaniasis in a patient with AIDS

1 reference

12 December 2020

Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

1 reference

12 December 2020

Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain

1 reference

12 December 2020

Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection

1 reference

12 December 2020

Use of IFN-gamma in patients with AIDS

1 reference

12 December 2020

Asymptomatic visceral leishmaniasis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

New perspectives on a subclinical form of visceral leishmaniasis

1 reference

12 December 2020

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

1 reference

12 December 2020

Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon

1 reference

12 December 2020

Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature

1 reference

12 December 2020

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma

1 reference

12 December 2020

Immunotherapy for parasitic disease

1 reference

12 December 2020

Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome

1 reference

12 December 2020

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine

1 reference

12 December 2020

Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

1 reference

12 December 2020

Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony

1 reference

12 December 2020

Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma

1 reference

12 December 2020

Progression of Kaposi's sarcoma under a combined interferon beta and interferon gamma therapy in AIDS patients

1 reference

12 December 2020

Visceral leishmaniasis in immunocompromised hosts

1 reference

12 December 2020

Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma

1 reference

12 December 2020

Fatal leishmaniasis in renal-transport patient

1 reference

12 December 2020

Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion.

1 reference

12 December 2020

Small intestinal involvement in visceral leishmaniasis

1 reference

12 December 2020

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

12 December 2020

Visceral leishmaniasis in HIV-infected patients

1 reference

12 December 2020

AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation

1 reference

12 December 2020

Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).

1 reference

12 December 2020

Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma

1 reference

12 December 2020

Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS.

1 reference

12 December 2020

[HIV infection and kala-azar]

1 reference

12 December 2020

Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients

1 reference

12 December 2020

Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment

1 reference

12 December 2020

Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma

1 reference

12 December 2020

Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Immunosuppression in Kenyan visceral leishmaniasis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00577752

1 reference

Dimensions Publication ID

27 July 2017

1032305761

0 references

1 reference